U.S. FDA issues EIR with VAI classification for Torrent Pharmaceuticals’ Indrad facility

H

hanuman

Active member
usfda-approved-black.jpg


Torrent Pharmaceuticals has announced that the U.S. FDA has issued an Establishment Inspection Report (EIR) for its manufacturing facility at Indrad, Gujarat. The inspection, conducted from June 3 to June 12, 2024, has been classified as Voluntary Action Indicated (VAI). The inspection process is now officially closed.

The post
You do not have permission to view link please Log in or Register
appeared first on
You do not have permission to view link please Log in or Register
.
 
You must log in or register to reply here.
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock